Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 17, Number 9—September 2011

Canine Serology as Adjunct to Human Lyme Disease Surveillance

Paul S. MeadComments to Author , Rohan Goel, and Kiersten J. Kugeler
Author affiliations: Author affiliation: Centers for Disease Control and Prevention, Fort Collins, Colorado, USA

Main Article


Counties meeting criteria for emergence of human Lyme disease during 2007–2009, by canine seroprevalence of Borrelia burgdorferi antibodies during 2001–2006, 46 US states*

Canine seroprevalence, 2001–2006, %† No. low-incidence counties,‡
2001–2006 No. (%) emergent counties,§
Unknown 2,065 96 (4.5)
0 240 1 (0.4)
0.1–0.5 174 1 (0.6)
0.51–1.0 101 4 (4.0)
1.1–5.0 122 33 (27.0)
>5.1 32 18 (56.3)

*All states except Alaska, Hawaii, Montana, and Nevada.
†Data from Figure 2 in Bowman et al. (8).
‡Counties with below average incidence of human Lyme disease (<4.7 cases/100,000 population).
§Counties with below average incidence in 2001–2006 and above in 2007–2009.
¶χ2 for trend 135.9, p<0.0001, for counties with known canine seroprevalence.

Main Article

  1. Bacon  RM, Kugeler  KJ, Mead  PS. Surveillance for Lyme disease—United States, 1992–2006. MMWR Surveill Summ. 2008;57:19.PubMedGoogle Scholar
  2. Herrington  JE Jr, Campbell  GL, Bailey  RE, Cartter  ML, Adams  M, Frazier  EL, Predisposing factors for individuals’ Lyme disease prevention practices: Connecticut, Maine, and Montana. Am J Public Health. 1997;87:20358. DOIPubMedGoogle Scholar
  3. Fine  AM, Brownstein  JS, Nigrovic  LE, Kimia  AA, Olson  KL, Thompson  AD, Integrating spatial epidemiology into a decision model for evaluation of facial palsy in children. Arch Pediatr Adolesc Med. 2011;165:617. DOIPubMedGoogle Scholar
  4. Tugwell  P, Dennis  DT, Weinstein  A, Wells  G, Shea  B, Nichol  G, Laboratory evaluation in the diagnosis of Lyme disease. Ann Intern Med. 1997;127:110923.PubMedGoogle Scholar
  5. Falco  RC, Smith  HA, Fish  D, Mojica  BA, Bellinger  MA, Harris  HL, The distribution of canine exposure to Borrelia burgdorferi in a Lyme-disease endemic area. Am J Public Health. 1993;83:130510. DOIPubMedGoogle Scholar
  6. Guerra  MA, Walker  ED, Kitron  U. Canine surveillance system for Lyme borreliosis in Wisconsin and northern Illinois: geographic distribution and risk factor analysis. Am J Trop Med Hyg. 2001;65:54652.PubMedGoogle Scholar
  7. Duncan  AW, Correa  MT, Levine  JF, Breitschwerdt  EB. The dog as a sentinel for human infection: prevalence of Borrelia burgdorferi C6 antibodies in dogs from southeastern and mid-Atlantic states. Vector Borne Zoonotic Dis. 2004;4:2219.PubMedGoogle Scholar
  8. Bowman  D, Little  SE, Lorentzen  L, Shields  J, Sullivan  MP, Carlin  EP. Prevalence and geographic distribution of Dirofilaria immitis, Borrelia burgdorferi, Ehrlichia canis, and Anaplasma phagocytophilum in dogs in the United States: results of a national clinic-based serologic survey. Vet Parasitol. 2009;160:13848. DOIPubMedGoogle Scholar
  9. IDEXX. Sensitivity and specificity of the SNAP® 4Dx® Test 2010 [updated 2010 Oct 1] [cited 2010 Oct 10].
  10. Little  SE, Heise  SR, Blagburn  BL, Callister  SM, Mead  PS. Lyme borreliosis in dogs and humans in the USA. Trends Parasitol. 2010;26:2138. DOIPubMedGoogle Scholar

Main Article

Page created: September 06, 2011
Page updated: September 06, 2011
Page reviewed: September 06, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.